Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
50.5M
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
34.7M
-
Shares change
-
+1.32M
-
Total reported value, excl. options
-
$833M
-
Value change
-
+$34M
-
Put/Call ratio
-
0.17
-
Number of buys
-
63
-
Number of sells
-
-40
-
Price
-
$24.02
Significant Holders of Mirum Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (MIRM) as of Q1 2023
127 filings reported holding MIRM - Mirum Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q1 2023.
Mirum Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (MIRM) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.7M shares
of 50.5M outstanding shares and own 68.69% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (4.19M shares), Frazier Life Sciences Management, L.P. (3.86M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.06M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.03M shares), Rock Springs Capital Management LP (1.8M shares), BlackRock Inc. (1.71M shares), Novo Holdings A/S (1.68M shares), RiverVest Venture Management LLC (1.62M shares), CITADEL ADVISORS LLC (1.37M shares), and VANGUARD GROUP INC (1.27M shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.